Skip to main content
SpringerLink
Log in

Schwerpunkt triple-negatives Mammakarzinom

Screening und Diagnostik

  • schwerpunkt
  • Published:
InFo Hämatologie + Onkologie Aims and scope

Die Diagnostik des triple-negativen Mammakarzinoms kann Untersuchende vor Herausforderungen stellen, etwa wenn karzinomtypische Zeichen fehlen. Lesen Sie im Folgenden, worauf zu achten ist, damit eine adäquate Diagnosestellung gelingt.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

1
2

Literatur

  1. Obdeijn IM et al. Should we screen BRCA1 mutation carriers only with MRI? A multicenter study. Breast Cancer Res Treat. 2014;144(3):577–82.

    Article  CAS  Google Scholar 

  2. Houssami N, Hunter K. The epidemiology, radiology and biological characteristics of interval breast cancers in population mammography screening. NPJ Breast Cancer. 2017;13;3:12

    Google Scholar 

  3. Dogan BE, Turnbull LW. Imaging of triple-negative breast cancer. Ann Oncol. 2012;23(Suppl 6):vi23–9

    PubMed  Google Scholar 

  4. Gao B et al. Mammographic and clinicopathological features of triple-negative breast cancer. Br J Radiol 2014;87:20130496

    Article  CAS  Google Scholar 

  5. Dogan BE et al. Multimodality imaging of triple receptor-negative tumors with mammography, ultrasound, and MRI. AJR Am J Roentgenol. 2010;194(4):1160–6

    Article  Google Scholar 

  6. Krizmanich-Conniff KM et al. Triple receptor-negative breast cancer: imaging and clinical characteristics. AJR Am J Roentgenol. 2012;199(2):458–64

    Article  Google Scholar 

  7. Naehrig D et al. Das dreifach negative Mammakarzinom. Von der Diagnostik zur Therapie. Info Onkologie. 2013;16(1):26–35

    Article  Google Scholar 

  8. Whitman GJ et al. Triple-negative breast cancer: what the radiologist needs to know. Semin Roentgenol. 2011;46(1):26–39

    Article  Google Scholar 

  9. Bae MS et al. Pretreatment MR imaging Features of Triple-negative Breast cancer: Association with Response to Neoadjuvant Chemotherapy and Recurrence-Free Survival. Radiology. 2016;281(2):392–400

    Article  Google Scholar 

  10. Groheux D et al. Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breastcancer. Eur J Nucl Med Mol Imaging. 2011;38(3):426–35

    Article  Google Scholar 

  11. Mavaddat N et al. Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE. J Natl Cancer Inst. 2013;105(11):812–22

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Radiologie und Nuklearmedizin, Universitätsspital Basel, Petersgraben 4, CH-4031, Basel, Schweiz

    Sabine Bucher & Sophie Dellas

Authors
  1. Sabine Bucher
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sophie Dellas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sabine Bucher.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bucher, S., Dellas, S. Screening und Diagnostik. Info Onkol. 22, 13–14 (2019). https://doi.org/10.1007/s15004-019-6468-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-019-6468-2

Search

Navigation